# Union Pacific Corp: financial statements, quarterly

UNP · NYSE · CIK 100885 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/unp.md) · [Financials](/companies/unp/financials.md) · [Filings](/companies/unp/filings.md) · [Insiders](/companies/unp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/unp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,159 d](/filings/0000100885-26-000037.md) | [6,031](/filings/0000100885-25-000151.md) | [6,007](/filings/0000100885-25-000253.md) | [6,091](/filings/0000100885-25-000321.md) | [6,121 d](/filings/0000100885-26-000037.md) | [6,027](/filings/0000100885-26-000155.md) | [6,154](/filings/0000100885-26-000250.md) | [6,244](/filings/0000100885-26-000321.md) | [6,085 d](/filings/0000100885-26-000037.md) | [6,217](/filings/0000100885-26-000155.md) | [6,864](/filings/0000100885-26-000250.md) | [7,197](/filings/0000100885-26-000321.md) |
| Operating income | $m | [2,407 d](/filings/0000100885-26-000037.md) | [2,372](/filings/0000100885-25-000151.md) | [2,400](/filings/0000100885-25-000253.md) | [2,416](/filings/0000100885-25-000321.md) | [2,525 d](/filings/0000100885-26-000037.md) | [2,371](/filings/0000100885-26-000155.md) | [2,525](/filings/0000100885-26-000250.md) | [2,549](/filings/0000100885-26-000321.md) | [2,401 d](/filings/0000100885-26-000037.md) | [2,458](/filings/0000100885-26-000155.md) | [2,763](/filings/0000100885-26-000250.md) | [2,943](/filings/0000100885-26-000321.md) |
| Interest expense | $m | [331 d](/filings/0001437749-24-003599.md) | [324](/filings/0001437749-24-013206.md) | [319](/filings/0001437749-24-023463.md) | [314](/filings/0001437749-24-032008.md) | [312 d](/filings/0000100885-26-000037.md) | [322](/filings/0000100885-26-000155.md) | [335](/filings/0000100885-26-000250.md) | [327](/filings/0000100885-26-000321.md) | [325 d](/filings/0000100885-26-000037.md) | [320](/filings/0000100885-26-000155.md) | [313](/filings/0000100885-26-000250.md) | [312](/filings/0000100885-26-000321.md) |
| Income tax | $m | [532 d](/filings/0000100885-26-000037.md) | [499](/filings/0000100885-25-000151.md) | [511](/filings/0000100885-25-000253.md) | [518](/filings/0000100885-25-000321.md) | [519 d](/filings/0000100885-26-000037.md) | [501](/filings/0000100885-26-000155.md) | [437](/filings/0000100885-26-000250.md) | [530](/filings/0000100885-26-000321.md) | [560 d](/filings/0000100885-26-000037.md) | [528](/filings/0000100885-26-000155.md) | [562](/filings/0000100885-26-000250.md) | [650](/filings/0000100885-26-000321.md) |
| Net income | $m | [1,652 d](/filings/0000100885-26-000037.md) | [1,641](/filings/0000100885-25-000151.md) | [1,673](/filings/0000100885-25-000253.md) | [1,671](/filings/0000100885-25-000321.md) | [1,762 d](/filings/0000100885-26-000037.md) | [1,626](/filings/0000100885-26-000155.md) | [1,876](/filings/0000100885-26-000250.md) | [1,788](/filings/0000100885-26-000321.md) | [1,848 d](/filings/0000100885-26-000037.md) | [1,701](/filings/0000100885-26-000155.md) | [1,993](/filings/0000100885-26-000250.md) | [2,076](/filings/0000100885-26-000321.md) |
| Diluted EPS | $ per share | not reported | [2.69](/filings/0000100885-25-000151.md) | [2.74](/filings/0000100885-25-000253.md) | [2.75](/filings/0000100885-25-000321.md) | not reported | [2.70](/filings/0000100885-26-000155.md) | [3.15](/filings/0000100885-26-000250.md) | [3.01](/filings/0000100885-26-000321.md) | not reported | [2.87](/filings/0000100885-26-000155.md) | [3.36](/filings/0000100885-26-000250.md) | [3.49](/filings/0000100885-26-000321.md) |
| Basic EPS | $ per share | not reported | [2.69](/filings/0000100885-25-000151.md) | [2.75](/filings/0000100885-25-000253.md) | [2.75](/filings/0000100885-25-000321.md) | not reported | [2.71](/filings/0000100885-26-000155.md) | [3.16](/filings/0000100885-26-000250.md) | [3.02](/filings/0000100885-26-000321.md) | not reported | [2.87](/filings/0000100885-26-000155.md) | [3.36](/filings/0000100885-26-000250.md) | [3.50](/filings/0000100885-26-000321.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0000100885-26-000037.md) | [0.9](/filings/0000100885-25-000151.md) | [1.1](/filings/0000100885-25-000253.md) | [0.9](/filings/0000100885-25-000321.md) | [1.0](/filings/0000100885-26-000037.md) | [1.4](/filings/0000100885-26-000155.md) | [1.1](/filings/0000100885-26-000250.md) | [0.8](/filings/0000100885-26-000321.md) | [1.3](/filings/0000100885-26-000321.md) | [0.7](/filings/0000100885-26-000155.md) | [1.6](/filings/0000100885-26-000250.md) | [2.2](/filings/0000100885-26-000321.md) |
| Current assets | $bn | [4.1](/filings/0000100885-25-000042.md) | [4.2](/filings/0001437749-24-013206.md) | [4.5](/filings/0001437749-24-023463.md) | [4.1](/filings/0001437749-24-032008.md) | [4.0](/filings/0000100885-26-000037.md) | [4.5](/filings/0000100885-25-000151.md) | [4.2](/filings/0000100885-25-000253.md) | [3.9](/filings/0000100885-25-000321.md) | [4.6](/filings/0000100885-26-000321.md) | [4.2](/filings/0000100885-26-000155.md) | [5.5](/filings/0000100885-26-000250.md) | [6.5](/filings/0000100885-26-000321.md) |
| Total assets | $bn | [67.1](/filings/0000100885-25-000042.md) | [67.3](/filings/0001437749-24-013206.md) | [67.8](/filings/0001437749-24-023463.md) | [67.6](/filings/0001437749-24-032008.md) | [67.7](/filings/0000100885-26-000037.md) | [68.5](/filings/0000100885-25-000151.md) | [68.6](/filings/0000100885-25-000253.md) | [68.6](/filings/0000100885-25-000321.md) | [69.7](/filings/0000100885-26-000321.md) | [69.6](/filings/0000100885-26-000155.md) | [71.2](/filings/0000100885-26-000250.md) | [72.6](/filings/0000100885-26-000321.md) |
| Current liabilities | $bn | [5.1](/filings/0000100885-25-000042.md) | [4.5](/filings/0001437749-24-013206.md) | [4.3](/filings/0001437749-24-023463.md) | [5.4](/filings/0001437749-24-032008.md) | [5.3](/filings/0000100885-26-000037.md) | [6.2](/filings/0000100885-25-000151.md) | [6.5](/filings/0000100885-25-000253.md) | [5.2](/filings/0000100885-25-000321.md) | [5.0](/filings/0000100885-26-000321.md) | [4.6](/filings/0000100885-26-000155.md) | [5.6](/filings/0000100885-26-000250.md) | [5.6](/filings/0000100885-26-000321.md) |
| Total liabilities | $bn | [52.3](/filings/0000100885-25-000042.md) | [51.6](/filings/0001437749-24-013206.md) | [51.3](/filings/0001437749-24-023463.md) | [51.0](/filings/0001437749-24-032008.md) | [50.8](/filings/0000100885-26-000037.md) | [52.5](/filings/0000100885-25-000151.md) | [52.3](/filings/0000100885-25-000253.md) | [51.3](/filings/0000100885-25-000321.md) | [51.2](/filings/0000100885-26-000321.md) | [50.2](/filings/0000100885-26-000155.md) | [50.5](/filings/0000100885-26-000250.md) | [50.6](/filings/0000100885-26-000321.md) |
| Long-term debt | $bn | [32.6](/filings/0001437749-24-003599.md) | not reported | not reported | not reported | [31.2](/filings/0000100885-25-000042.md) | not reported | not reported | not reported | [31.8](/filings/0000100885-26-000037.md) | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0000100885-25-000042.md) | [0.3](/filings/0001437749-24-013206.md) | [0.3](/filings/0001437749-24-023463.md) | [0.2](/filings/0001437749-24-032008.md) | [0.0](/filings/0000100885-26-000037.md) | [0.0](/filings/0000100885-25-000151.md) | [0.0](/filings/0000100885-25-000253.md) | [0.0](/filings/0000100885-25-000321.md) | [0.0](/filings/0000100885-26-000037.md) | [0.0](/filings/0000100885-26-000155.md) | [0.0](/filings/0000100885-26-000250.md) | [0.0](/filings/0000100885-26-000321.md) |
| Shareholders' equity | $bn | [14.8](/filings/0000100885-26-000037.md) | [15.7](/filings/0000100885-25-000253.md) | [16.5](/filings/0000100885-25-000321.md) | [16.6](/filings/0000100885-25-000321.md) | [16.9](/filings/0000100885-26-000321.md) | [16.0](/filings/0000100885-26-000250.md) | [16.3](/filings/0000100885-26-000321.md) | [17.3](/filings/0000100885-26-000321.md) | [18.5](/filings/0000100885-26-000321.md) | [19.4](/filings/0000100885-26-000250.md) | [20.7](/filings/0000100885-26-000321.md) | [22.0](/filings/0000100885-26-000321.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,395 d](/filings/0000100885-26-000037.md) | [2,122](/filings/0000100885-25-000151.md) | [1,911 d](/filings/0000100885-25-000253.md) | [2,651 d](/filings/0000100885-25-000321.md) | [2,662 d](/filings/0000100885-26-000037.md) | [2,210](/filings/0000100885-26-000155.md) | [2,333 d](/filings/0000100885-26-000250.md) | [2,522 d](/filings/0000100885-26-000321.md) | [2,225 d](/filings/0000100885-26-000037.md) | [2,440](/filings/0000100885-26-000155.md) | [3,076 d](/filings/0000100885-26-000250.md) | [2,786 d](/filings/0000100885-26-000321.md) |
| Capital expenditure | $m | [1,024 d](/filings/0000100885-26-000037.md) | [797](/filings/0000100885-25-000151.md) | [902 d](/filings/0000100885-25-000253.md) | [831 d](/filings/0000100885-25-000321.md) | [922 d](/filings/0000100885-26-000037.md) | [906](/filings/0000100885-26-000155.md) | [936 d](/filings/0000100885-26-000250.md) | [950 d](/filings/0000100885-26-000321.md) | [999 d](/filings/0000100885-26-000037.md) | [937](/filings/0000100885-26-000155.md) | [873 d](/filings/0000100885-26-000250.md) | [1,024 d](/filings/0000100885-26-000321.md) |
| Dividends paid | $m | [793 d](/filings/0000100885-26-000037.md) | [795](/filings/0000100885-25-000151.md) | [793 d](/filings/0000100885-25-000253.md) | [815 d](/filings/0000100885-25-000321.md) | [810 d](/filings/0000100885-26-000037.md) | [804](/filings/0000100885-26-000155.md) | [795 d](/filings/0000100885-26-000250.md) | [819 d](/filings/0000100885-26-000321.md) | [818 d](/filings/0000100885-26-000037.md) | [821](/filings/0000100885-26-000155.md) | [819 d](/filings/0000100885-26-000250.md) | [844 d](/filings/0000100885-26-000321.md) |
| Share repurchases | $m | [0.0 d](/filings/0000100885-26-000037.md) | [0.0](/filings/0000100885-25-000151.md) | [100 d](/filings/0000100885-25-000253.md) | [731 d](/filings/0000100885-25-000321.md) | [674 d](/filings/0000100885-26-000037.md) | [1,420](/filings/0000100885-26-000155.md) | [1,259 d](/filings/0000100885-26-000250.md) | [0.0 d](/filings/0000100885-26-000321.md) | [0.0 d](/filings/0000100885-26-000037.md) | [0.0](/filings/0000100885-26-000155.md) | [26.0 d](/filings/0000100885-26-000250.md) | [0.0 d](/filings/0000100885-26-000321.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [612](/filings/0001437749-24-013206.md) | [610](/filings/0001437749-24-023463.md) | [610](/filings/0001437749-24-032008.md) | [610](/filings/0000100885-25-000151.md) | [610](/filings/0000100885-25-000253.md) | [609](/filings/0000100885-25-000321.md) | [602](/filings/0000100885-26-000155.md) | [595](/filings/0000100885-26-000250.md) | [593](/filings/0000100885-26-000321.md) | [594](/filings/0000100885-26-000155.md) | [594](/filings/0000100885-26-000250.md) | [595](/filings/0000100885-26-000321.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 594,250,416 at 2026-10-16, from the cover of the [10-Q filed 2026-10-22](/filings/0000100885-26-000321.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.